Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis
<p>Abstract</p> <p>Background</p> <p>Myelin Oligodendrocyte Glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) is the most commonly used mouse model for multiple sclerosis (MS). During the of progression of EAE, microglia, the immunocompetent cel...
Main Authors: | Tsirka Stella E, Wu Muzhou, Bhasin Madhuri |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-07-01
|
Series: | BMC Immunology |
Online Access: | http://www.biomedcentral.com/1471-2172/8/10 |
Similar Items
-
Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis.
by: Muzhou Wu, et al.
Published: (2012-01-01) -
Microglial inhibitory factor (MIF/TKP) mitigates secondary damage following spinal cord injury
by: Jaime Emmetsberger, et al.
Published: (2012-09-01) -
Targeted Blood Brain Barrier Opening With Focused Ultrasound Induces Focal Macrophage/Microglial Activation in Experimental Autoimmune Encephalomyelitis
by: Katharina Schregel, et al.
Published: (2021-05-01) -
Macrophage migration inhibitory factor: a study of the effects on the central nervous system microenvironment in experimental autoimmune encephalomyelitis
by: Cox, Gina Mavrikis
Published: (2011) -
Tuftsin Combines With Remyelinating Therapy and Improves Outcomes in Models of CNS Demyelinating Disease
by: Kaitlyn K. Thompson, et al.
Published: (2018-11-01)